Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Greenwald

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Oncogene|February 1, 2002
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarraysF M Selaru, T Zou, Y Xu, et al.
Oncogene|July 3, 1997
FHIT gene alterations in esophageal cancer and ulcerative colitis (UC)T T Zou, J Lei, Y Q Shi, et al.
Gastroenterology|July 3, 1998
Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosisH M Cawley, S J Meltzer, V M De Benedetti, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 9, 2017
Safety and efficacy of endoscopic spray cryotherapy for esophageal cancerF C Tsai, S Ghorbani, B D Greenwald, et al.
Oncogene|February 2, 2006
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesisS Wang, M Zhan, J Yin, et al.
Gastroenterology|January 1, 1997
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasmsR F Souza, J Lei, J Yin, et al.
Journal of the National Cancer Institute|November 18, 2000
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinomaK Kawakami, J Brabender, R V Lord, et al.
Human Cell|September 1, 1996
Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasmsR F Souza, L Garrigue-Antar, J Lei, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncogene|February 1, 2002
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarraysF M Selaru, T Zou, Y Xu, et al.
Oncogene|July 3, 1997
FHIT gene alterations in esophageal cancer and ulcerative colitis (UC)T T Zou, J Lei, Y Q Shi, et al.
Gastroenterology|July 3, 1998
Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosisH M Cawley, S J Meltzer, V M De Benedetti, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|September 9, 2017
Safety and efficacy of endoscopic spray cryotherapy for esophageal cancerF C Tsai, S Ghorbani, B D Greenwald, et al.
Oncogene|February 2, 2006
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesisS Wang, M Zhan, J Yin, et al.
Gastroenterology|January 1, 1997
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasmsR F Souza, J Lei, J Yin, et al.
Journal of the National Cancer Institute|November 18, 2000
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinomaK Kawakami, J Brabender, R V Lord, et al.
Human Cell|September 1, 1996
Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasmsR F Souza, L Garrigue-Antar, J Lei, et al.
Pageof 3